Jonathan Feelemyer, MS

Beth Israel Medical Center
The Baron Edmond de Rothschild Chemical Dependency Institute
160 Water Street
24th Floor
New York, NY
USA 10038

Papers:
3395.0 Changes in quality of life (WHO-QOLBREF) and addiction severity index (ASI) among participants in opiate substitution programs in low and middle income countries: An international systematic review 4119.0 Injecting drug use as a public health problem in transitional, low and middle income countries 4163.0 Retention of participants in opiate substitution programs in low and middle-income countries: An international systematic review